Last reviewed · How we verify

NCT03336684: ERADEL

Evaluation of Rheumatoid Arthritis Disease Education Literature

Completed NA Last updated 24 March 2020
What this trial tests

NA trial testing Patient education in Rheumatoid Arthritis in 376 participants. Completed in 30 June 2019.

Timeline
18 December 2017
Primary endpoint
31 May 2019
30 June 2019

Quick facts

Lead sponsorUniversiti Sains Malaysia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment376
Start date18 December 2017
Primary completion31 May 2019
Estimated completion30 June 2019
Sites2 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Sains Malaysia — full company profile →

Who can join

18 and older, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rheumatoid arthritis is an inflammatory disease that results in joint inflammation, pain and swelling. It may progress to advance stages that render patients unable to carry out their daily activities. It also results in joints deformity and is a leading cause of disability globally. Patient education plays an important role in the management of disease. Adequate patient knowledge and awareness about disease may help in incorporating the ailment in daily life. The purpose of this study is to evaluate the benefit of a disease education literature in Urdu language and with culturally relevant illustration for rheumatoid arthritis patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Patient education

Trials testing the same drug.

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

Other Universiti Sains Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03336684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing